Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2025-12-25 @ 8:45 PM
Study NCT ID:
NCT03541369
Status:
TERMINATED
Last Update Posted:
2024-10-10
First Post:
2018-05-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-18
First Submit QC Date:
None
Study First Post Date:
2018-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-02
Results First Submit QC Date:
None
Results First Post Date:
2024-10-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-15
Last Update Post Date:
2024-10-10
Last Update Post Date Type:
ACTUAL